After controlling for age, gender, tumour location, tumour grade, tumour stage, perineural invasion, vascular thrombi, diabetes mellitus history, baseline CA19-9 serum level, adjuvant chemotherapy, and adjuvant radiotherapy treatment history, MUC1 absence and MUC2 presence were identified as independent risk factors. This evidence concerns the gene MUC2 and neoplasm.